We found that BCL10-P4 treatment induced significant apoptosis of the CB-SMOC-dependent DLBCL cells (TMD8 and SU-DHL4 cell lines) in a dose-dependent manner, while little apoptosis induction was observed for the CB-SMOC-independent DLBCL cells (OCI-LY1 cell line) (Figure 5E-F). Here, BCL10 is linked to diffuse large B-cell lymphoma.